Bret Jensen is back on the show to give us all an update on what is important and newsworthy in the biotech space right now.
(Press play button to listen or click here to download.)
Subscribe: iTunes | Android | RSS
I’d like to see more content like this!
(It can be hard to find a good picture for “biotech.”)
Some highlights:
- The interesting ride in biotech in recent months.
- What the sector needs in order to move forward.
- Update on latest biotech and pharma witch hunts.
- What to expect from the sector after the election.
- Updates on overall merger and acquisition activity and what to look for.
- Why Pfizer and Allergan could make some big moves.
- Why Gilead is under big pressure and what they may do about it.
- What his two prime targets are for being bought out.
- Thoughts on what will likely happen regarding a rate hike.
- The big mistake that so many biotech investors make.
Companies mentioned: Allergan, Sanofi, Acadia, Biogen, Merck, Portola, Mylan
I hope you enjoy the interview.
Best,
Brian
Content You’ll Also Like
080 Mark Bern – The Desperate Earnings Cover-Up Of 2016
082 Mark Hibben – Apple Event Recap: Why The iPhone 7 Will Struggle
072 Bret Jensen – Everything You Need To Know About Biotech Right Now
085 Bret Jensen – Everything You Need To Know About Biotech Right Now
